Primary Record
Eprosartan
- In stock
- 2,761 g
- Purity
- 99.6 %
- CAS
- 133040-01-4
Compound Identifiers & Properties
- CAS
- 133040-01-4
- PubChem CID
- 5281037
- SMILES
- CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O
- Canonical SMILES
- CCCCc1ncc(/C=C(\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1
Names & Synonyms
- Eprosartan
- Teveten
- 133040-01-4
- Eprosartanum
- Eprozar
- [3H]eprosartan
- [3H]-eprosartan
- Eprosartan mesilate
- Teveten (TN)
- Eprosartan (Standard)
- Eprosartan (USAN/INN)
- AC1NQXXN
- CHEMBL813
- EPROSARTAN [MI]
- Eprosartan [USAN:BAN:INN]
- EPROSARTAN [INN]
- RefChem:590997
- 2KH13Z0S0Y
- EPROSARTAN [HSDB]
- EPROSARTAN [USAN]
- EPROSARTAN MESYLATE
- SK&F 108566
- SK&F-108566
- UNII-2KH13Z0S0Y
- SKF-108566
- EPROSARTAN [VANDF]
- D09TYW
- D0T7US
- Eprosartan [USAN:INN:BAN]
- SCHEMBL4025
- CHEBI:4814
- EPROSARTAN [WHO-DD]
- DTXSID0022989
- GTPL588
- Teveten; SK&F108566
- C23H24N2O4S
- HSDB 7521
- BIDD:GT0030
- OROAFUQRIXKEMV-LDADJPATSA-N
- DTXCID002989
- GTPL3940
- orb1702349
- CHEBI:94094
- C09CA02
- SK-108566
- MFCD00897872
- BCPP000239
- GLXC-08125
- HMS2089O10
- BCP02353
- MSK10510
- [3H]SK&F 108566
- BDBM50011977
- C23-H24-N2-O4-S
- EBC-27048
- MFCD20923872
- STK618317
- ZINC29319828
- (4-carboxybenzyl)imidazole-5-acrylic acid
- AKOS005552473
- (E)-4-((2-Butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoic acid
- ACN-045558
- BCP9000656
- CB11812
- CID5281037
- CS-O-01474
- DB00876
- FE22770
- HY-117743R
- SKB 108566
- (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid
- NCGC00164557-01
- NCGC00164557-06
- NCGC00164557-11
- NCGC00164557-13
- AN-32112
- BS-20679
- HY-117743
- J380.264G
- J553.931E
- LS-172855
- TL8000785
- 2485B
- CS-0067582
- NS00000388
- ST24035050
- 40E014
- A11121
- C07467
- D04040
- H11955
- 66929-EP2270011A1
- 66929-EP2277879A1
- 66929-EP2295406A1
- 66929-EP2295430A2
- 66929-EP2295431A2
- 66929-EP2298772A1
- 66929-EP2298779A1
- 66929-EP2301923A1
- 66929-EP2301931A1
- 66929-EP2305219A1
- 66929-EP2305670A1
- 66929-EP2308839A1
- AB01275448-01
- AB01275448_02
- EN300-7397751
- 4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid
- A888228
- L000248
- Q784717
- SR-05000001450
- I06-2216
- SR-05000001450-1
- BRD-K67977190-066-01-5
- BRD-K67977190-066-02-3
- BRD-K67977190-066-03-1
- (E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid
- (E)-alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid
- 4-({2-butyl-5-[(1E)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
- methyl 4-[(2-butyl-5-formylimidazol-1-yl)methyl]benzoate
- 2-Thiophenepropanoic acid, alpha-((2-butyl-1-((4-carboxyphenyl)methyl)-lH-imidazol-5-yl)methylene)-, (E)-
- 4-({2-butyl-5-[(1E)-2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
- 4-[[2-butyl-5-[(E)-3-hydroxy-3-oxo-2-(thiophen-2-ylmethyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid
- 4-[[2-butyl-5-[(E)-2-carboxy-3-(2-thienyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid
- (E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]imidazol-5-yl]-2-(2-thienylmethyl)-2-propenoic acid
- 144143-96-4
- 2-Thiophenepropanoic acid, alpha-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (alphaE)-
- 4-({2-butyl-5-[(1E)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
- 4-({2-butyl-5-[(1E)-2-carboxy-2-[(thiophen-2-yl)methyl]eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
- (E)-1-(4-METHOXY-2,3,6-TRIMETHYL-PHENYL)-3-METHYL-PENT-1-EN-4-YN-3-OL
- (E)-2-BUTYL-1-(P-CARBOXYBENZYL)-.ALPHA.-2-THENYLIMIDAZOLE-5-ACRYLIC ACID
- (E)-3-[2-Butyl-1-(4-carboxybenzyl)-1H-imidazol-5-yl]-2-(2-thienylmethyl)acrylic acid
- 1-[4-Carboxybenzyl]-2-butyl-alpha-[(2-thienyl)methyl]-1H-imidazole-5-propenoic acid
- 4-[[2-butyl-5-(2-carboxy-3-thiophen-2-yl-prop-1-enyl)imidazol-1-yl]methyl]benzoic acid
- 4-[[2-butyl-5-(2-carboxy-3-thiophen-2-ylprop-1-enyl)-1-imidazolyl]methyl]benzoic acid
- 4-[2-Butyl-5-(2-carboxy-3-thiophen-2-yl-propenyl)-imidazol-1-ylmethyl]-benzoic acid
- (aE)-a-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid; (E)-2-Butyl-1-(p-carboxybenzyl)-a-2-thenylimidazole-5-acrylic Acid; Navixen; SKB 108566; SKF 108566; Teveten;
- (alpha E)-alpha-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic acid
- (alphaE)-alpha-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid
- (E)-3-(2-n-butyl-1-((4-carboxyphenyl)methyl)-1H-imidazol-5-yl)-2-(2-thienyl)methyl-2-propenoic acid
- (E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]-imidazol-5-yl]-2-(2-thienyl methyl)-2-propenoic acid
- (E)-3-[2-butyl-1-[(4-carboxyphenyl)methyl]-imidazol-5-yl]-2-(2-thienylmethyl)-2-propenoic acid
- (E)-4-((2-butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-enyl)-1H-imidazol-1-yl)methyl)benzoic acid
- (E)-alpha((2-butyl-1-((4-carboxyphenyl)methyl)-1H-imidazole-5-yl)methylene)-2-thiopheneproprionic acid
- (E)-alpha-[[2-Butyl-1-[(4-carboxyphenyl)-methyl]-1H-imidazol-5-yl]methylene]-2-thiophene Propanoic Acid
- (E)-alpha-[[2-butyl-1-[(4carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophene propanoic acid
- 133040-03-6
- 2-THIOPHENEPROPANOIC ACID, .ALPHA.-((2-BUTYL-1-((4-CARBOXYPHENYL)METHYL)-LH-IMIDAZOL-5-YL)METHYLENE)-, (E)-
- 2-Thiophenepropanoic acid, |A-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-, (|AE)-
- 4-((2-butyl-5-((1E)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoic acid
- 4-((2-butyl-5-((E)-3-hydroxy-3-oxo-2-(thiophen-2-ylmethyl)prop-1-enyl)imidazol-1-yl)methyl)benzoic acid
- 4-[(2-butyl-5-{2-carboxy-2-[(thiophen-2-yl)methyl]eth-1-en-1-yl}-1H-imidazol-1-yl)methyl]benzoic acid